Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...
Moderna (MRNA) won the $590 million contract ... to review agreements for vaccine production," a spokesperson for HHS told Bloomberg in a written statement. Moderna's mRNA technology was behind ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results